Alx Oncology Holdings (ALXO)
$5.60 -$0.12 (-2.10%) 4:37 PM 07/04/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$314.16M -
Day's Range
$5.56 - $6.09 -
Volume
1,035,948 -
52 Week Low / High
$3.94 - $17.82 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
ALXO's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 2
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $17.07
- Target Price
Company News
-
ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference — Jan 3rd, 2024
ALX Oncology SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, announced today that Jason Lettmann, Chief Exe...
Similar Stocks
No similar stocks found.
|
$